EX-99 2 a04-12641_1ex99.htm EX-99

Exhibit 99

 

 

*coherent
PRESS RELEASE

Editorial Contact:

For Release:

Leen Simonet

IMMEDIATE

(408) 764-4161

November 3, 2004

 

No. 893

 

Coherent, Inc. Fourth Quarter and Fiscal Year End Results Include Increased Profit and Improved Gross Margin

 

Coherent, Inc. (Santa Clara, CA) (NASDAQ:COHR) today announced financial results for its fourth fiscal quarter ended October 2, 2004 with sales of $133.2 million and income from continuing operations of $9.8 million ($0.32 per diluted share).  Fourth quarter results included a $3.2 million ($2.0 million after-tax or $0.07 per diluted share) recovery on the sale of a note receivable.

 

Sales and net loss from continuing operations for the corresponding prior year quarter were $101.5 million and $25.7 million ($0.86 per diluted share), respectively.  In comparison, sales for the immediately preceding quarter’s results were $128.0 million and income from continuing operations was $5.2 million ($0.17 per diluted share), which included a gain of $0.7 million ($0.02 per diluted share) from the sale of certain technology.

 

Orders received during the quarter ended October 2, 2004 were $132.7 million, representing a 27% increase over the prior year quarter and a 6% increase from orders received in the immediately preceding quarter.  Backlog of $154.6 million at October 2, 2004 compared to a backlog of $155.1 million at July 3, 2004 and $127.7 million at September 27, 2003.

 

John Ambroseo, Coherent’s President and Chief Executive Officer commented, “During the past fiscal year we delivered strong results with sales increasing by 22% and orders up 29% over the prior year.   These results are directly attributable to the strategic investments in research and development and acquisitions made over the preceding 24 months.  Our greater profitability also benefited from improved operating efficiencies and better leverage of our infrastructure.  For the most recent quarter, we recognized higher bookings in both business segments on a sequential basis.  The resiliency in our order stream is a direct result from design wins in leading edge applications.”

 

Year-to-date sales of $495.0 million and net income of $17.7 million ($0.58 per diluted share) compared to the prior year sales of  $406.2 million and a net loss of $45.9 million ($1.56 per share).  Orders received for the twelve month period ended October 2, 2004 were $521.8 million, representing a 29% increase over orders received in the same period last year.

 

Electro-Optics segment sales of $109.2 million for the three months ended October 2, 2004 were 30% higher than sales during the comparable prior year period and increased 4% from the three months ended July 3, 2004.  Incoming orders of $108.7 million represent a 22% improvement over the fourth fiscal quarter of 2003 and an increase of 5% from orders received in the immediately preceding quarter.  Sales and incoming orders for fiscal year 2004 were $409.3 million and $427.9 million, 26% and 27% higher, respectively, than during fiscal year 2003.

 

Lambda Physik segment sales of $24.0 million for the three months ended October 2, 2004 represent a 35% increase from the corresponding prior year period and a 7% increase from the immediately preceding quarter.  Incoming orders of $24.0 million for the fourth quarter of fiscal 2004 were 52% higher than the fourth fiscal quarter of 2003 and represent a 12% increase in orders from the immediately preceding third fiscal quarter.  Sales and incoming orders for the fiscal year ended October 2, 2004 were $85.7 million and $93.9 million, respectively, and were 5% higher and 39% higher than during fiscal year 2003.

 

Ambroseo continued, “Coherent has seeded its markets during the past year and these applications are poised to exhibit growth.  We will continue to focus on fundamentals that should allow us to drive margin expansion and increase profitability into fiscal year 2005 and beyond.”

 



 

Summarized statement of operations financial information is as follows (unaudited, in thousands except per share data):

 

 

 

Three Months Ended

 

Year Ended

 

 

 

Oct. 2,
2004

 

July 3,
2004

 

Sept. 27,
2003

 

Oct. 2,
2004 (A)

 

Sept. 27,
2003 (A)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales (B)

 

$

133,244

 

$

127,951

 

$

101,519

 

$

494,954

 

$

406,235

 

Cost of sales (C)

 

73,679

 

72,964

 

71,134

 

287,395

 

257,467

 

Gross profit

 

59,565

 

54,987

 

30,385

 

207,559

 

148,768

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

16,512

 

15,505

 

14,124

 

62,476

 

50,751

 

In-process research and development (D)

 

 

 

1,908

 

 

6,338

 

Selling, general and administrative (E)

 

29,585

 

28,626

 

28,905

 

113,301

 

103,929

 

Restructuring, impairment and other charges (F)

 

(3,348

)

18

 

12,052

 

(3,093

)

35,163

 

Intangibles amortization

 

1,495

 

1,504

 

1,968

 

6,698

 

5,147

 

Total operating expenses

 

44,244

 

45,653

 

58,957

 

179,382

 

201,328

 

Income (loss) from operations

 

15,321

 

9,334

 

(28,572

)

28,177

 

(52,560

)

Other income (expense), net (G)

 

(920

)

350

 

(210

)

22

 

(4,854

)

Income (loss) from continuing operations before income taxes and minority interest

 

14,401

 

9,684

 

(28,782

)

28,199

 

(57,414

)

Provision (benefit) for taxes (H)

 

4,616

 

4,261

 

253

 

10,890

 

(6,640

)

Income (loss) from continuing operations before minority interest

 

9,785

 

5,423

 

(29,035

)

17,309

 

(50,774

)

Minority interest (B)

 

(17

)

(269

)

3,344

 

192

 

4,241

 

Income (loss) from continuing operations

 

9,768

 

5,154

 

(25,691

)

17,501

 

(46,533

)

Income from discontinued operations

 

 

 

642

 

218

 

642

 

Net income (loss)

 

$

9,768

 

$

5,154

 

$

(25,049

)

$

17,719

 

$

(45,891

)

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share, diluted:

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from continuing operations

 

$

0.32

 

$

0.17

 

$

(0.86

)

$

0.57

 

$

(1.58

)

Income from discontinued operations

 

 

 

0.02

 

0.01

 

0.02

 

Net income (loss)

 

$

0.32

 

$

0.17

 

$

(0.84

)

$

0.58

 

$

(1.56

)

 

 

 

 

 

 

 

 

 

 

 

 

Shares used in computation:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

30,351

 

30,243

 

29,857

 

30,179

 

29,448

 

Diluted

 

30,673

 

30,620

 

29,857

 

30,544

 

29,448

 

 


(A)      The fiscal year ended October 2, 2004 includes 53 weeks while the fiscal year ended September 27, 2003 includes 52 weeks.

 

(B)        The quarters ended October 2, 2004 and July 3, 2004 include $1,762 and $2,181 of net sales, respectively, from an entity consolidated under FIN 46R.  This entity’s net income for the corresponding periods of  $135 and $380, respectively, were eliminated through minority interest.  Our future results will not include the results of this entity as we have sold our interest in the entity.

 

(C)        Cost of sales in the quarter ended March 29, 2003 included an additional inventory reserve requirement of $2,743 ($1,220 after-tax and net of minority interest ($0.04 per diluted share)) due to lower forecasted outlook in Lambda Physik’s lithography business.

 

(D)       In-process research and development expense for the quarter ended September 27, 2003 includes a $1,908 ($0.06 per diluted share) charge related to our purchase of 33.9% of the outstanding shares of Lambda Physik AG.  In-process research and development expense for the quarter ended June 28, 2003 includes a $4,430 ($0.15 per diluted share) charge related to the purchase of Positive Light, Inc. in April 2003.

 

(E)         Includes $2,538 ($1,327 after-tax and net of minority interest ($0.04 per diluted share)) of severance costs incurred by Lambda Physik in the quarter ended September 27, 2003.

 

(F)         Includes a $3,241 ($2,002 after-tax ($0.07 per diluted share)) recovery on the sale of a previously impaired note receivable in the quarter ended October 2, 2004.  The quarter ended September 27, 2003 includes an additional $746 ($448 after-tax ($0.02 per diluted share)) charge primarily related to the previously communicated termination of activities in the Telecom Actives Group, $9,613 ($7,967 after-tax ($0.27 per diluted share)) for the impairment of long-lived assets related to excess manufacturing capacity and $1,693 ($1,016 after-tax ($0.03 per diluted share)) of lease termination costs.  Goodwill impairment charges in the quarter ended March 29, 2003 were $2,358 ($1,769 net of minority interest ($0.06 per diluted share)).  The quarter ended December 29, 2002 includes a $13,378 ($8,288 after-tax ($0.28 per diluted share)) charge related to the termination of activities in the Telecom Actives Group, a $3,060 ($2,672 after tax ($0.09 per diluted share)) charge related to our exit from the passive telecom market and a $3,723 ($2,306 after-tax ($0.08 per diluted share)) allowance against a note receivable.

 



 

(G)        The fiscal year ended September 27, 2003 includes a one-time gain of $1,479 ($0.05 per diluted share) related to the sale of 5.2 million shares of Lumenis, Ltd, a $4,400 ($1,953 after-tax and net of minority interest ($0.07 per diluted share)) settlement fee related to the cancellation of a customer contract received by Lambda Physik and an impairment charge on the Lumenis shares held by Coherent of $10,212 ($10,212 after-tax ($0.35 per diluted share)).

 

(H)       Included in the September 27, 2003 quarter end is a $5,566 after-tax and net of minority interest ($0.19 per diluted share) charge related to the establishment of a valuation allowance against Lambda Physik’s deferred tax assets and an income tax benefit of $1,203 ($0.04 per diluted share) for refund of prior years’ taxes.  The June 28, 2003 quarter end includes a tax benefit related to a refund of prior year taxes of $908 ($0.03 per diluted share).

 

Summarized balance sheet information is as follows (unaudited, in thousands):

 

 

 

Oct. 2,
2004

 

Sept. 27,
2003 (A)

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and short-term investments

 

$

170,734

 

$

134,671

 

Restricted cash, cash equivalents and short-term investments (B)

 

15,343

 

15,284

 

Short-term equity investments

 

 

277

 

Accounts receivable, net

 

96,825

 

73,118

 

Inventories

 

104,698

 

100,147

 

Prepaid expenses and other assets

 

62,572

 

75,485

 

Total current assets

 

450,172

 

398,982

 

Property and equipment, net

 

166,054

 

146,399

 

Restricted cash, cash equivalents and short-term investments (B)

 

23,580

 

38,660

 

Other assets

 

122,049

 

125,324

 

Total assets

 

$

761,855

 

$

709,365

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Current portion of long-term obligations

 

$

13,700

 

$

14,140

 

Accounts payable

 

17,648

 

17,632

 

Other current liabilities

 

73,181

 

69,341

 

Total current liabilities

 

104,529

 

101,113

 

Long-term obligations

 

14,215

 

27,911

 

Other long-term liabilities

 

54,530

 

36,483

 

Total stockholders’ equity

 

588,581

 

543,858

 

Total liabilities and stockholders’ equity

 

$

761,855

 

$

709,365

 

 


(A)       Derived from audited financial statements for the year ended September 27, 2003.

(B)       Represents cash, cash equivalents and short-term investments restricted under our notes payable arrangement ($30,360), for the purchase of the remaining outstanding shares of Lambda Physik AG ($8,401) and other ($162) at October 2, 2004.

 



 

Reconciliation of GAAP to Non-GAAP summarized statement of operations (unaudited, in thousands, after-tax and net of minority interest):

 

 

 

Three Months Ended

 

Year Ended

 

 

 

Oct. 2,
2004

 

July 3,
2004

 

Sept. 27,
2003

 

Oct. 2,
2004

 

Sept. 27,
2003

 

GAAP net income (loss)

 

$

9,768

 

$

5,154

 

$

(25,049

)

$

17,719

 

$

(45,891

)

Recovery on the sale of note receivable

 

(2,002

)

 

 

(2,002

)

 

Sale of technology

 

 

(663

)

 

(663

)

 

Gain on contract settlements (1)

 

 

 

 

 

(1,953

)

Restructuring, impairment and other charges (2)

 

 

 

9,431

 

142

 

24,466

 

Write-down of Lumenis investment

 

 

 

 

 

10,212

 

Discontinued operations

 

 

 

(642

)

(218

)

(642

)

Tax benefit for refunds related to prior years’ taxes

 

 

 

(1,203

)

 

(2,111

)

In-process research and development

 

 

 

1,908

 

 

6,338

 

Gain on sale of Lumenis investment

 

 

 

 

 

(1,479

)

Lambda Physik severance costs (3)

 

 

 

1,327

 

 

1,327

 

Deferred tax asset valuation allowance (4)

 

 

 

5,566

 

 

5,566

 

Non-GAAP net income (loss)

 

$

7,766

 

$

4,491

 

$

(8,662

)

$

14,978

 

$

(4,167

)

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP net income (loss) per diluted share

 

$

0.25

 

$

0.15

 

$

(0.29

)

$

0.49

 

$

(0.14

)

 


(1)         Net of minority interest of $(1,015)

(2)         Net of minority interest of $589

(3)         Net of minority interest of $349

(4)         Net of minority interest of $2,238

 

The Company’s conference call scheduled for 1:30 p.m. PT today will include discussions relative to the current quarter results and some comments regarding forward looking guidance on future operating performance.

 

The statements in this press release that relate to future plans, events or performance, including statements such as Coherent has seeded its markets during the past year and these applications are poised to exhibit growth and we will continue to focus on fundamentals that should allow us to drive margin expansion and increase profitability into fiscal year 2005 and beyond, are forward-looking statements.  Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated to currency adjustments, contract cancellations, manufacturing risks, competitive factors, and uncertainties pertaining to customer orders, demand for products and services, and development of markets for the Company’s products and services and other risks identified in the Company’s SEC filings.  Actual results, events and performance may differ materially.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  The Company undertakes no obligation to update these forward-looking statements as a result of events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

The Company may provide non-GAAP financial measures (as defined by the SEC in Regulation G) in our earnings conference call and in any other company presentations during the quarter.  Non-GAAP financial measures are intended to supplement the user’s overall understanding of the Company’s current financial performance and its future prospects. Any non-GAAP financial measures are not intended to replace the Company’s GAAP results.  The Company’s intention is to include the most directly comparable GAAP financial measures and a reconciliation of the differences between each non-GAAP financial measure used and the most directly comparable GAAP financial measure.

 

Readers are encouraged to refer to the risk disclosures described in the Company’s reports on Forms 10-K, 10-Q and 8K, as applicable.

 

Founded in 1966, Coherent, Inc. is a Standard & Poor’s SmallCap 600 company and a world leader in providing photonics based solutions to the commercial and scientific research markets. Please direct any questions to Leen Simonet, Chief Financial Officer at 408-764-4161. For more information about Coherent, visit the Company’s Web site at http://www.coherent.com/ for product and financial updates.

 

5100 Patrick Henry Dr.  P. O. Box 54980, Santa Clara, California  95056–0980.  Telephone (408) 764-4000